Background illustration for clinical trials search

Paid Clinical Trials Detroit

Discover 1,727 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Removing Barriers: Community Partnering for Innovative Solutions to the Opioid Crisis

for
Opioid Use Disorder, Alcohol Use Disorder,
Location: Ypsilanti MI, Ann Arbor MI
Sponsor: University of Michigan

Sex: All

Age: 18+

Code: NCT05665179

Recruiting

Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COACH-APP Trial

for
Other
Location: Ypsilanti MI, Chelsea MI, Reed City MI, Chicago IL,
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18+

Code: NCT06904391

Recruiting

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

for
Extensive Stage Small Cell Lung Cancer
Location: Ann Arbor MI, Chicago IL, Sioux Falls SD, Houston TX,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT06598306

Phase 1, Recruiting

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

for
Ulcerative Colitis, Crohn's Disease
Location: Ypsilanti MI, Westlake OH, Mentor OH, Wyoming MI,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06581328

Phase 4, Recruiting

Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs

for
Cardiac Failure, Graft Rejection
Location: Ann Arbor MI, Pittsburgh PA, Chicago IL, Nashville TN,
Sponsor: Northwestern University

Sex: All

Age: 0 - 18

Code: NCT06532890

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

for
Propionic Acidemia
Location: Ann Arbor MI, Toronto, Chicago IL, Philadelphia PA,
Sponsor: ModernaTX, Inc.

Sex: All

Age: 0+

Code: NCT04159103

Phase 1, Phase 2, Recruiting

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

for
Crohn Disease, Colitis, Ulcerative
Location: Ypsilanti MI, Charlottesville VA, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0+

Code: NCT06651281

Phase 3, Recruiting

A Study of ASP3082 in Adults With Advanced Solid Tumors

for
Solid Tumor
Location: Ypsilanti MI, Maumee OH, Cleveland OH, Buffalo NY,
Sponsor: Astellas Pharma Inc

Sex: All

Age: 18+

Code: NCT05382559

Phase 1, Recruiting

CtDNA Based MRD Testing for NAC Monitoring in TNBC

for
TNBC - Triple-Negative Breast Cancer, Minimal Residual Disease
Location: Ypsilanti MI, Peoria IL, York PA, Washington DC DC,
Sponsor: Personalis Inc.

Sex: Female

Age: 18+

Code: NCT06230185

Recruiting

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

for
Ovarian Cancer
Location: Ann Arbor MI, Grand Rapids MI, Centerville OH,
Sponsor: Daiichi Sankyo

Sex: Female

Age: 18+

Code: NCT06819007

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

for
CRC (Colorectal Cancer)
Location: Ann Arbor MI, Maumee OH, Columbus OH, Pittsburgh PA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07284849

Phase 3, Recruiting

BoxX-NoAF Clinical Trial

for
Post Operative Atrial Fibrillation,
Location: Ypsilanti MI, Ann Arbor MI, Toledo OH, Cleveland OH,
Sponsor: AtriCure, Inc.

Sex: All

Age: 65+

Code: NCT06989775

Recruiting

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

for
Acral Lentiginous Melanoma,
Location: Ann Arbor MI, Brighton MI, Toledo OH, Perrysburg OH,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT04511013

Phase 2, Recruiting

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

for
Breast Cancer, TNBC - Triple-Negative Breast Cancer,
Location: Ann Arbor MI, Goshen IN, Cincinnati OH, La Crosse WI,
Sponsor: Tempus AI

Sex: All

Age: 18 - 70+

Code: NCT07211178

Recruiting

Multi-Center Study of Clinical and Inflammatory Outcomes in Intensive Cardiac Rehabilitation and Traditional Cardiac Rehabilitation Programs

for
Cardiovascular Diseases
Location: Ypsilanti MI, Asheville NC
Sponsor: Pritikin ICR

Sex: All

Age: 18+

Code: NCT06424119

Recruiting

Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer

for
HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer
Location: Ypsilanti MI, Cleveland OH, Hinsdale IL, Hershey PA,
Sponsor: SynDevRx, Inc.

Sex: All

Age: 18+

Code: NCT05455619

Phase 1, Phase 2, Recruiting

A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum

for
Pyoderma Gangrenosum
Location: Ann Arbor MI, Flint MI, Cleveland OH, Columbus OH,
Sponsor: LEO Pharma

Sex: All

Age: 18+

Code: NCT06624670

Phase 3, Recruiting

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

for
Pediatric Migraine
Location: Ann Arbor MI, Cleveland OH, Grand Rapids MI, Amherst NY,
Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT04649242

Phase 3, Recruiting

A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation

for
Atrial Fibrillation
Location: Ypsilanti MI, Rochester NY, Lexington KY,
Sponsor: Biosense Webster, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07523750

Recruiting

A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata

for
Alopecia Areata
Location: Clarkston MI, Bexley OH, Upper Saint Clair PA,
Sponsor: AnaptysBio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05205070

Phase 2, Recruiting